DrugPatentWatch Database Preview
Amag Pharma Usa Company Profile
» See Plans and Pricing
What is the competitive landscape for AMAG PHARMA USA, and when can generic versions of AMAG PHARMA USA drugs launch?
AMAG PHARMA USA has one approved drug.
There are eight US patents protecting AMAG PHARMA USA drugs.
There are thirty-eight patent family members on AMAG PHARMA USA drugs in thirteen countries.
Summary for Amag Pharma Usa
| International Patents: | 38 |
| US Patents: | 8 |
| Tradenames: | 3 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Amag Pharma Usa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amag Pharma Usa | MAKENA (AUTOINJECTOR) | hydroxyprogesterone caproate | SOLUTION;SUBCUTANEOUS | 021945-004 | Feb 14, 2018 | RX | Yes | Yes | 8,562,564 | Start Trial | Y | Start Trial | |||
| Amag Pharma Usa | MAKENA | hydroxyprogesterone caproate | SOLUTION;INTRAMUSCULAR | 021945-001 | Feb 3, 2011 | AP1 | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Amag Pharma Usa | MAKENA (AUTOINJECTOR) | hydroxyprogesterone caproate | SOLUTION;SUBCUTANEOUS | 021945-004 | Feb 14, 2018 | RX | Yes | Yes | 9,629,959 | Start Trial | Y | Start Trial | |||
| Amag Pharma Usa | MAKENA PRESERVATIVE FREE | hydroxyprogesterone caproate | SOLUTION;INTRAMUSCULAR | 021945-002 | Feb 19, 2016 | AP | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Amag Pharma Usa | MAKENA (AUTOINJECTOR) | hydroxyprogesterone caproate | SOLUTION;SUBCUTANEOUS | 021945-004 | Feb 14, 2018 | RX | Yes | Yes | 9,180,259 | Start Trial | Y | Start Trial | |||
| Amag Pharma Usa | MAKENA (AUTOINJECTOR) | hydroxyprogesterone caproate | SOLUTION;SUBCUTANEOUS | 021945-004 | Feb 14, 2018 | RX | Yes | Yes | 8,021,335 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Amag Pharma Usa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Amag Pharma Usa | MAKENA (AUTOINJECTOR) | hydroxyprogesterone caproate | SOLUTION;SUBCUTANEOUS | 021945-004 | Feb 14, 2018 | RE44846 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Amag Pharma Usa Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2015516845 | Start Trial |
| European Patent Office | 2833944 | Start Trial |
| Hungary | E042286 | Start Trial |
| Brazil | PI0614025 | Start Trial |
| Japan | 6640907 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2013152323 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
